Evaluation of exclusion through bundling in pharmaceutical rebate contracts

Pharma production

CRA advised counsel to a branded manufacturer on bringing suit against a competitor with respect to bundling of rebates. CRA examined the potential for a rebate “trap” limiting substitution and market segments that suggest its existence.

Meet our team